These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1772490)

  • 1. Clozapine concentrations and clinical response in schizophrenic patients.
    Jeffries JJ
    Am J Psychiatry; 1991 Oct; 148(10):1406-7. PubMed ID: 1772490
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine concentrations and clinical response in schizophrenic patients.
    Owen JA; Delva NJ; Lawson JS
    Am J Psychiatry; 1992 Aug; 149(8):1120-1. PubMed ID: 1636820
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine and NMS.
    Buckley PF; Meltzer HY
    Br J Psychiatry; 1993 Apr; 162():566. PubMed ID: 8329060
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
    Perry PJ; Miller DD; Arndt SV; Cadoret RJ
    Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
    Potkin SG; Bera R; Gulasekaram B; Costa J; Hayes S; Jin Y; Richmond G; Carreon D; Sitanggan K; Gerber B
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma clozapine levels and clinical benefit.
    Greenberg WM
    J Clin Psychiatry; 1995 Nov; 56(11):535-6. PubMed ID: 7592511
    [No Abstract]   [Full Text] [Related]  

  • 7. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: report of a case and results of a clozapine rechallenge.
    Goates MG; Escobar JI
    J Clin Psychopharmacol; 1992 Apr; 12(2):139-40. PubMed ID: 1573039
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
    Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
    J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
    Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.
    Miller DD; Fleming F; Holman TL; Perry PJ
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():117-21. PubMed ID: 7961554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of chloral hydrate and sodium amytal during clozapine initiation.
    Dickson RA; Williams R; Dalby JT
    Can J Psychiatry; 1994 Apr; 39(3):132-4. PubMed ID: 8033016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
    Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
    Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome associated with clozapine use.
    Anderson ES; Powers PS
    J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood clozapine level and therapeutic adjustment].
    Préterre P
    Encephale; 1995 Jun; 21 Spec No 3():53-7. PubMed ID: 7628343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
    Meltzer HY
    Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine decreases smoking in patients with chronic schizophrenia.
    McEvoy J; Freudenreich O; McGee M; VanderZwaag C; Levin E; Rose J
    Biol Psychiatry; 1995 Apr; 37(8):550-2. PubMed ID: 7619979
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.